– Alar’s Lead Asset ALA-1000 Potentially is the First Three-Month LAI Treatment for OUD – RICHMOND, Va., Oct. 11, 2023 /PRNewswire/ — Indivior PLC (LSE/Nasdaq: INDV), a leading addiction treatment company, today announced that it has gained exclusive global rights to develop,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.